BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Lumendi’s Dilumen Ig Endolumenal Interventional Grasper for Minimally Invasive Endoscopic Therapies Now Available in U.S.

  The DiLumen Ig is a flexible endoscopic tool intended to grasp and manipulate tissue within the digestive tract under direct endoscopic visualization.

  November 10, 2017

   · 

  3 min read
• Business

  Alphatec Holdings Reports Third Quarter 2017 Financial Results

  Total revenue of $23.1 million; U.S. commercial revenue of $20.7 million.

  November 10, 2017

   · 

  13 min read
• Pixium Vision to Present Bionic Vision Systems Update at Jefferies Healthcare Conference, November 15-16, London

  Khalid Ishaque, Chief Executive Officer, will be presenting as well as meeting with investors.

  November 10, 2017

   · 

  3 min read
• BioCapital

  Johns Hopkins Hospital Study Data to be Presented at USCAP 2018

  An abstract discussing the results of a study performed by researchers at The Johns Hopkins Hospital in Baltimore, USA, has been accepted by the USCAP for presentation at their annual conference in March 2018.

  November 10, 2017

   · 

  1 min read
• BioMidwest

  Esperion to Participate in Fireside Chat at the Stifel 2017 Healthcare Conference

  Esperion Therapeutics today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat with investors at the Stifel 2017 Healthcare Conference in New York City on Tuesday, November 14, 2017 at 8:45 a.m. Eastern Time.

  November 10, 2017

   · 

  4 min read
• Pharm Country

  Onconova Therapeutics Announces Pricing of Public Offering of Common Stock

  The company has agreed to sell approximately 920,000 shares of its common stock for gross proceeds of approximately $1.38 million.

  November 10, 2017

   · 

  4 min read
• Drug Development

  Celgene’s Ozanimod Successful in Clinical Trials for Multiple Sclerosis

  Celgene recently announced results from two phase III trials evaluating the efficacy and safety of the drug ozanimod.

  November 10, 2017

   · 

  4 min read
• Business

  Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017

  Management will host a conference call to discuss the second quarter financial results for fiscal year 2018 ended September 30th and provide an update on recent business developments.

  November 10, 2017

   · 

  4 min read
• Business

  Argos Reports Third Quarter 2017 Financial Results and Operational Highlights

  Revenue for the three months ended September 30, 2017 was $53,000 compared to $147,000 for the same period in 2016.

  November 10, 2017

   · 

  13 min read
• Policy

  Elanco, Aratana Announce Positive Opinion on GALLIPRANT (grapiprant tablets) in Europe

  Following the positive opinion, the EC will complete the regulatory process for a final decision on the Marketing Authorisation in early 2018.

  November 10, 2017

   · 

  3 min read